Controlled Pharmacodynamics with Melanin Targeted Drug Delivery to the Eye

Description of the granted funding

Ocular diseases are common and growing problem that endangers the vision of millions of patients. Drug treatment of glaucoma is accomplished with frequently applied eye drops that are difficult to use, leading to poor patient compliance. In age-related macular degeneration the medications are given as direct injections to the eye, but this is burdensome to patients and healthcare. This project aims to develop long acting therapeutics that are based on drug binding to melanin pigment in the eye. New compounds will be designed, synthesized and tested. Furthermore, computational models are developed to facilitate the development of long-acting ocular injections and eye drops for the treatment of glaucoma and age-related macular degeneration.
Show more

Starting year

2021

End year

2023

Granted funding

Arto Urtti Orcid -palvelun logo
250 000 €

Funder

Research Council of Finland

Funding instrument

Academy projects

Other information

Funding decision number

343138

Fields of science

Pharmacy

Research fields

Farmasia

Identified topics

eyes, eye diseases